An explainable artificial intelligence system for prognostic assessment and decision support in diabetic foot ulcer care: a multicentre derivation and validation study with prospective randomised evaluation
An explainable artificial intelligence system for prognostic assessment and decision support in diabetic foot ulcer care: a multicentre derivation and validation study with prospective randomised evaluation. // eClinicalMedicine. – URL: https://www.sciencedirect.com/science/article/pii/S2589537026005377?dgcid=rss_sd_all
An explainable artificial intelligence system for prognostic assessment and decision support in diabetic foot ulcer care: a multicentre derivation and validation study with prospective randomised evaluation. eClinicalMedicine. https://www.sciencedirect.com/science/article/pii/S2589537026005377?dgcid=rss_sd_all
“An explainable artificial intelligence system for prognostic assessment and decision support in diabetic foot ulcer care: a multicentre derivation and validation study with prospective randomised evaluation.” eClinicalMedicine.
@article{article43963,
title = {An explainable artificial intelligence system for prognostic assessment and decision support in diabetic foot ulcer care: a multicentre derivation and validation study with prospective randomised evaluation},
journal = {eClinicalMedicine},
url = {https://www.sciencedirect.com/science/article/pii/S2589537026005377?dgcid=rss_sd_all}
}
Nature Medicine, Published online: 20 November 2026; doi:10.1038/s41591-026-04781-0 Concerns about use of placebo control in clinical trials of Obinutuzumab β for aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
Nature Medicine, Published online: 20 November 2026; doi:10.1038/s41591-026-04782-z Reply to: Concerns about use of placebo control in clinical trials of Obinutuzumab β for aquaporin-4 antibody positive neuromyelitis optica spectrum disorder